Association of MTG8 (ETO/CDR), a leukemia-related protein, with serine/threonine protein kinases and heat shock protein HSP90 in human hematopoietic cell lines

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 60-68

  Komori, Atsumasa ^a,b   Sueoka, Eisaburo ^a   Fujiki, Hirota ^a   Ishii, Masaru ^c   Kozu, Tomoko ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

^c Hospital   (Japan)

Author keywords

Leukemogenesis; MTG8C kinase; MTG8N kinase

Indexed keywords

HEAT SHOCK PROTEIN 90; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0033005390     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00666.x     Document Type: Article

References (37)

1. Rowley, J. D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res., 44, 3159-3168 (1984).
2. Miyoshi, H., Shimizu, K., Kozu, T., Museki, N., Kaneko, Y. and Ohki, M. t(8:21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1. Proc. Natl. Acad. Sci. USA, 88, 10431-10434 (1991).
3. Erickson, P., Gao, J., Chang, K.-S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. and Drabkin, H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood, 80, 1825-1831 (1992).
4. Kozu, T., Miyoshi, H., Shimizu, K., Maseki, N., Kaneko, Y., Asou, H., Kamada, N. and Ohki, M. Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood, 82, 1270-1276 (1993).
5. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. and Ohki, M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J., 12, 2715-2721 (1993).
6. Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soeda, E. and Ohki, M. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res., 23, 2762-2769 (1995).
7. Meyers, S., Lenny, N. and Hiebert, S. W. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol., 15, 1974-1982 (1995).
8. Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S. W. and Nimer, S. D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene, 11, 2667-2674 (1995).
9. Lenny, N., Meyers, S. and Hiebert, S. W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene, 11, 1761-1769 (1995).
10. Westendorf, J. J., Yaniamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E. and Hiebert, S. W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol., 18, 322-333 (1998).
11. Rhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G. and Zhang, D.-E. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8:21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA, 93, 11895-11900 (1996).
12. Klampfer, L., Zhang, J., Zelenetz, A. O., Uchida, H. and Nimer, S. D. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA, 93, 14059-14064 (1996).
13. Erickson, P. F., Robinson, M., Owens, G. and Drabkin, H. A. The ETO portion of acute myeloid leukemia t(8:21) fusion transcript encodes a highly evolutionary conserved, putative transcription factor. Cancer Res., 54, 1782-1786 (1994).
14. Era, T., Asou, N., Kunisada, T., Yamasaki, H., Asou, H., Kamada, N., Nishikawa, S.-I., Yamaguchi, K. and Takatsuki, K. Identification of two transcripts of AML1/ ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosom. Cancer, 13, 25-33 (1995).
15. + hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood. 88, 1813-1823 (1996).
16. Sueoka, E., Sueoka, N., Okabe, S., Komori, A., Suganuma, M., Kozu, T. and Fujiki, H. Tumourigenicity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells. Br. J. Haematol., 101, 737-742 (1998).
17. Parsell, D. A. and Lindquist, S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet., 21, 437-496 (1993).
18. Asou, H., Tashiro, S., Hamamoto, K., Otsuji, A., Kita, K. and Kamuda, N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8:21 chromosome translocation. Blood, 77, 2031-2036 (1991).
19. Matozaki, S., Nakagawa, T., Kawaguchi, R., Aozaki, R., Tsutsumi, M., Muruyama, T., Koizumi, T., Nishimura, R., Isobe, T. and Chihara, K. Establishment of a myeloid leukemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Br. J. Haematol., 89, 805-811 (1995).
20. Hibi, M., Lin, A., Smeal, T., Minden, A. and Karin, M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7, 2135-2148 (1993).
21. Kamps, M. P. and Sefton, B. M. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. Anal. Biochem., 176, 22-27 (1989).
22. Haystead, C. M. M., Gregory, P., Sturgill, T. W. and Haystead, T. A. J. γ-Phosphate-linked ATP-Sepharose for the affinity purification of protein kinases. Rapid purification to homogeneity of skeletal muscle mitogen-activated protein kinase kinase. Eur. J. Biochem., 214, 459-467 (1993).
23. Kameshita, I. and Fujisawa, H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183, 139-143 (1989).
24. Fujiki, H. and Suganuma, M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res., 61, 143-194 (1993).
25. Rebbe, N. F., Ware, J., Bertina, R. M. Modrich P. and Stafford, D. W. Nucleolide sequence of a cDNA for a member of the human 90 kDa heat-shock protein family. Gene, 53, 235-245 (1987).
26. Prodromou, C., Poe, S. M. O'Brien, R., Ladbury, J. E., Piper, P. W. and Pearl, L. H. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell, 90, 65-75 (1997).
27. Gross, C. T. and McGinnins, W. DHAF-1, a novel protein that binds an essential region in a Deformed response element. EMBO J., 15, 1961-1970 (1996).
28. Kozu, T., Komori, A., Sueoka, E., Fujiki, H., Kaneko, Y., Matsui, T., Uehara, T., Seino, Y. and Ishii, M. Significance of MTG8 in leukemogenesis. Leukemia, 11(S3), 297-298 (1997).
29. Lutterbach, B., Sun, D., Schuetz, S. D. and Hiebert, S. W. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol., 18, 3604-3611 (1998).
30. Pratt, W. B. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med., 217, 420-434 (1998).
31. Sehneider, C., Sepp-Lorenzino, L., Nimmesgern, E., Ouerfelli, O., Danishefsky, S., Rosen, N. and Hartl, F. U. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc. Natl. Acad. Sci. USA, 93, 14536-14541 (1996).
32. Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U. and Pavletich, N. P. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 89, 239-250 (1997).
33. v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. USA, 91, 8324-8328 (1994).
34. Schulte, T. W., Blagosklonny, M. V., Romanova, L., Mushinski, J. F., Monia, B. P. Johnston, J. F., Nguyen, P., Trepel, J. and Neckers, L. M. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol. Cell. Biol., 16, 5839-5845 (1996).
35. Whitesell, L. and Cook, P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol., 10, 705-712 (1996).
36. Kitabayashi, I., Ida, K., Morohoshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y. and Ohki, M. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8 (ETO/ CDR) family, MTGR1. Mol. Cell. Biol., 18, 846-858 (1998).
37. Gamou, T., Kitamura, E., Hosoda, F., Shimizu, K., Shinohara, K., Hayashi, Y., Nagase, T., Yokoyama, Y. and Ohki, M. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood, 91, 4028-4037 (1998).